Two Sigma Advisers
WGS icon

Two Sigma Advisers’s GeneDx Holdings WGS Stock Holding History

Two Sigma Advisers’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,187
Closed -$545K – 2149
2025
Q4 		$545K Buy
4,187
+227
+6% +$31.2K ﹤0.01% 1748
2025
Q3 		$427K Sell
3,960
-1,827
-32% -$199K ﹤0.01% 1828
2025
Q2 		$534K Sell
5,787
-1,500
-21% -$118K ﹤0.01% 1719
2025
Q1 		$645K Sell
7,287
-35,955
-83% -$3.12M ﹤0.01% 1670
2024
Q4 		$3.32M Buy
+43,242
New +$3.02M 0.01% 886
2023
Q2 		– Sell
-6,655
Closed -$80.2K – 2683
2023
Q1 		$80.2K Buy
6,655
+4,543
+215% +$60.6K ﹤0.01% 2407
2022
Q4 		$18.4K Buy
+2,112
New +$46.5K ﹤0.01% 2432
2022
Q3 		– Sell
-1,533
Closed -$64K – 2746
2022
Q2 		$64K Buy
1,533
+945
+161% +$64.1K ﹤0.01% 2451
2022
Q1 		$60K Sell
588
-3,054
-84% -$339K ﹤0.01% 2565
2021
Q4 		$536K Buy
+3,642
New +$814K ﹤0.01% 1881

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers's WGS Position: Q1 2026 in Review

Two Sigma Advisers sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 4,187 shares — an estimated $545K sold.

Two Sigma Advisers first reported a position in WGS in Q4 2021 and held it in 10 quarters. The position peaked at $3.32M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Two Sigma Advisers reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 4,187 GeneDx Holdings shares in Q1 2026, an estimated $545K.
  • Two Sigma Advisers first reported a position in GeneDx Holdings in Q4 2021 and held it in 10 quarters.
  • Two Sigma Advisers's GeneDx Holdings position peaked at $3.32M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.